Literature DB >> 2992989

Emission tomography with 99mTc-pyrophosphate in the diagnosis of acute myocardial infarction.

L Pöyhönen, A Uusitalo, A Virjo.   

Abstract

Electrocardiograms (ECG) and enzyme criteria are usually used to confirm the diagnosis of acute myocardial infarction in the case of chest pain. However, ECG is not always diagnostic. Elevated enzyme values may be due to causes other than myocardial infarction. In uncertain cases, the ECG and enzyme criteria can be supplemented by emission tomography, performed with technetium pyrophosphate that will accumulate in the site of infarction. Twenty-nine patients with suspected acute myocardial infarction were studied with emission tomography. Of these 12 had acute transmural infarction. Both enzyme tests and ECG were diagnostic in only 7 of these 12 cases, 4 had positive enzyme tests but a nondiagnostic ECG and in one case neither enzymes nor ECG were diagnostic. In 11 patients the infarcted myocardial area was detected with emission tomography. Six patients had acute nontransmural infarction. Only 2 of these had positive emission tomography. The chest pain was not due to infarction in 11 patients. All these patients had negative emission tomography. The sensitivity of emission tomography was 92% and specificity 100% in transmural acute infarction. In nontransmural infarction the specificity was only 33%. Emission tomography is a valuable diagnostic tool. It may be the decisive method when ECG and enzymes are not diagnostic. Emission tomography also shows the localization and size of the infarcted area in the myocardium.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992989     DOI: 10.1007/bf00252739

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  Distributions of several agents useful in imaging myocardial infarcts.

Authors:  F J Bonte; R W Parkey; K D Graham; J G Moore
Journal:  J Nucl Med       Date:  1975-02       Impact factor: 10.057

2.  Myocardial scintigraphy with technetium-99m stannous pyrophosphate: an insensitive test for nontransmural myocardial infarction.

Authors:  B M Massie; E H Botvinick; J A Werner; K Chatterjee; W W Parmley
Journal:  Am J Cardiol       Date:  1979-02       Impact factor: 2.778

3.  Pyrophosphate myocardial imaging.

Authors:  K P Lyons; H G Olson; W S Aronow
Journal:  Semin Nucl Med       Date:  1980-04       Impact factor: 4.446

Review 4.  Imaging with infarct-avid agents.

Authors:  H R Schelbert; E Henze; G Wisenberg
Journal:  Crit Rev Diagn Imaging       Date:  1981

5.  Measurement of infarct size using single photon emission computed tomography and technetium-99m pyrophosphate: a description of the method and comparison with patient prognosis.

Authors:  B L Holman; S Z Goldhaber; C M Kirsch; J F Polak; B J Friedman; R J English; J Wynne
Journal:  Am J Cardiol       Date:  1982-09       Impact factor: 2.778

Review 6.  Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy.

Authors:  J T Willerson; R W Parkey; F J Bonte; S E Lewis; J Corbett; L M Buja
Journal:  Semin Nucl Med       Date:  1980-01       Impact factor: 4.446

Review 7.  Myocardial infarct imaging with technetium-99m phosphates.

Authors:  R W Parkey; F J Bonte; L M Buja; E M Stokely; J T Willerson
Journal:  Semin Nucl Med       Date:  1977-01       Impact factor: 4.446

8.  Quantitation of experimental canine infarct size with multipinhole and rotating-slanthole tomography.

Authors:  S E Lewis; E M Stokely; M D Devous; F J Bonte; L M Buja; R W Parkey; J T Willerson
Journal:  J Nucl Med       Date:  1981-11       Impact factor: 10.057

Review 9.  Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis.

Authors:  J A Lott; J M Stang
Journal:  Clin Chem       Date:  1980-08       Impact factor: 8.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.